The Directorate Common of Commerce Cures (DGTR) launched the investigation final month following a petition by home drugmaker Lupin Ltd, which alleged that imports had been being dumped at unfairly low costs, hurting Indian producers.
The investigation comes as India ramps up efforts to counter unfair commerce practices that drawback home industries. The commerce treatments physique issued 15 remaining findings of such practices in September throughout sectors starting from glass fiber and metal to photo voltaic cells and chemical merchandise.
The DGTR, in a press release on Monday, named Lupin because the home business participant and Chinese language producer Wuhan Wuyao Prescribed drugs Co. Ltd among the many international respondents.
It stated there was proof of dumping and damage, with imports undercutting home costs.
The probe will cowl the interval April 2024-March 2025, and will lead to anti-dumping duties if the findings verify damage to Indian business.The DGTR initiated 13 new anti-dumping and countervailing circumstances in September, protecting imports largely from China and South Korea.
